Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham Weizman

Showing results (1-10 of 608) with videos related to

Pageof 61
Sort By:
International Clinical Psychopharmacology|October 21, 2020
Management of anxiety disorders in children with attention-deficit hyperactivity disorder: a narrative reviewPavel Golubchik, Abraham Weizman
Journal of Clinical Psychopharmacology|May 26, 2023
Beneficial Effect of Quetiapine on Sleep, Anxiety, Depression and Myalgia Symptoms in a Patient With Post-COVID-19 ConditionMichael Poyurovsky, Abraham Weizman
Lancet (London, England)|April 17, 2002
Seasonality of birth in patients with type 1 diabetesDavid Gurwitz, Abraham Weizman
International Journal of Psychiatry in Clinical Practice|September 30, 2017
The effect of methylphenidate treatment on suspiciousness in children with ADHD alone or comorbid with ODDPavel Golubchik, Abraham Weizman
Psychosomatics|April 21, 2009
Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresisPavel Golubchik, Abraham Weizman
The Israel Journal of Psychiatry and Related Sciences|November 6, 2008
Drug industry, psychopharmacology, and mental health care needs: where do we go from here?Ronnen Segman, Abraham Weizman
Clinical Neuropharmacology|April 3, 2021
Quetiapine for Bipolar Depressive Episode in Obsessive-Compulsive Disorder Patients Maintained on Selective Serotonin Reuptake Inhibitor TreatmentMichael Poyurovsky, Abraham Weizman
Drugs|May 10, 2020
Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT<sub>2a</sub> Receptor AntagonistsMichael Poyurovsky, Abraham Weizman
Clinical Neuropharmacology|August 30, 2021
Low-Dose Quetiapine Fumarate (50 mg) for Obsessive-Compulsive Disorder Patients With Comorbid Bipolar DepressionMichael Poyurovsky, Abraham Weizman
Journal of Child and Adolescent Psychopharmacology|April 12, 2017
The Possible Effect of Methylphenidate Treatment on Empathy in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder, Both With and Without Comorbid Oppositional Defiant DisorderPavel Golubchik, Abraham Weizman
Pageof 61

Showing results (1-10 of 608) with videos related to

Sort By:
Pageof 61
International Clinical Psychopharmacology|October 21, 2020
Management of anxiety disorders in children with attention-deficit hyperactivity disorder: a narrative reviewPavel Golubchik, Abraham Weizman
Journal of Clinical Psychopharmacology|May 26, 2023
Beneficial Effect of Quetiapine on Sleep, Anxiety, Depression and Myalgia Symptoms in a Patient With Post-COVID-19 ConditionMichael Poyurovsky, Abraham Weizman
Lancet (London, England)|April 17, 2002
Seasonality of birth in patients with type 1 diabetesDavid Gurwitz, Abraham Weizman
International Journal of Psychiatry in Clinical Practice|September 30, 2017
The effect of methylphenidate treatment on suspiciousness in children with ADHD alone or comorbid with ODDPavel Golubchik, Abraham Weizman
Psychosomatics|April 21, 2009
Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresisPavel Golubchik, Abraham Weizman
The Israel Journal of Psychiatry and Related Sciences|November 6, 2008
Drug industry, psychopharmacology, and mental health care needs: where do we go from here?Ronnen Segman, Abraham Weizman
Clinical Neuropharmacology|April 3, 2021
Quetiapine for Bipolar Depressive Episode in Obsessive-Compulsive Disorder Patients Maintained on Selective Serotonin Reuptake Inhibitor TreatmentMichael Poyurovsky, Abraham Weizman
Drugs|May 10, 2020
Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT<sub>2a</sub> Receptor AntagonistsMichael Poyurovsky, Abraham Weizman
Clinical Neuropharmacology|August 30, 2021
Low-Dose Quetiapine Fumarate (50 mg) for Obsessive-Compulsive Disorder Patients With Comorbid Bipolar DepressionMichael Poyurovsky, Abraham Weizman
Journal of Child and Adolescent Psychopharmacology|April 12, 2017
The Possible Effect of Methylphenidate Treatment on Empathy in Children Diagnosed with Attention-Deficit/Hyperactivity Disorder, Both With and Without Comorbid Oppositional Defiant DisorderPavel Golubchik, Abraham Weizman
Pageof 61